Drug Type Small molecule drug |
Synonyms Hydroquinone/tretinoin/fluocinolone-acetonide, Tri-Luma |
Action agonists, inhibitors |
Mechanism GR agonists(Glucocorticoid receptor agonists), RARα agonists(Retinoic acid receptor alpha agonists), RARβ2 agonists(Retinoic acid receptor beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (18 Jan 2002), |
Regulation- |
Molecular FormulaC24H30F2O6 |
InChIKeyFEBLZLNTKCEFIT-VSXGLTOVSA-N |
CAS Registry67-73-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Melanosis | United States | 18 Jan 2002 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lentigo | Phase 2 | Chile | - | 01 Aug 2008 |
Not Applicable | 50 | Cryotherapy (CRY-AC3® device)+Tri-luma (Group 1) | iwbjadtpxe(ttcfgwfqkh) = qwsnzotdyy sochnwpeuw (elrnsdyodt, 7.0) View more | - | 17 Sep 2020 | ||
Cryotherapy (CRY-AC3® device) (Group 2) | iwbjadtpxe(ttcfgwfqkh) = diokutoriz sochnwpeuw (elrnsdyodt, 11.0) View more | ||||||
Phase 4 | 56 | (Intense Pulsed Light (IPL) / Tri-Luma® Cream) | nyjcjzdaht = cuutnfmwim slmjawrrug (lvqrqxrtim, ozaxqxltci - fuqijvrrxo) View more | - | 11 Jan 2010 | ||
Cetaphil (Intense Pulsed Light (IPL) / Inactive Control Cream) | nyjcjzdaht = ekmesgfqtj slmjawrrug (lvqrqxrtim, qiyahwsklh - adoqsnwzae) View more |